Pharmaceutical packaging requires a greater knowledge of materials and a greater intensity
of testing than most other packed products, not to mention a sound knowledge of …

Parenteral drug products are protected by appropriate primary packaging to protect against
environmental factors, including potential microbial contamination during shelf life duration …

Providing a well-written and easy-to-read review of the subject, this reference describes the
most recent breakthroughs in the validation and execution of testing schemes for parenteral …

Capping completes the closure of parenteral drug products in the final packaging container
and is critical in maintaining an integral seal to ensure product quality. Residual seal force …

The vial capping process is a critical unit operation during drug product manufacturing, as it
could possibly generate cosmetic defects or even affect container closure integrity. Yet there …

As the complexities of the pharmaceuticals needed to prevail over serious diseases
continue to grow, the need for technologies to enable their efficient storage and delivery are …

Capping equipment used in good manufacturing practice manufacturing features different
designs and a variety of adjustable process parameters. The overall capping result is a …

Sufficient rubber stopper sealing performance throughout the entire sealed product life cycle
is essential for maintaining container closure integrity in the parenteral packaging industry …

A new major chapter dealing with container closure integrity was released by the United
States Pharmacopeial Convention. Chapter< 1207> provides a significant amount of …

A vial-capping process for lyophilization stopper configurations was previously quantified
using residual seal force (RSF). A correlation between RSF and container closure integrity …